DexTech Medical AB
DEX · Spotlight Stock Market
Public Market Listing
DEXSpotlight Stock Market
Live quotes, historical charts, and market capitalization for DexTech Medical AB are available on Yahoo Finance.
View quote & market cap on Yahoo Finance ↗External market data link · No third-party exchange redistribution
Assets
(1 total)
1Total Assets
0Approved
0Phase 3 / Filed
1Phase 1–2 / Early
1Diseases
| Target & Modality | |||
|---|---|---|---|
| Phase 1/2 | Bone mineral (hydroxyapatite) / osteoclastsSmall molecule | Multiple Myeloma |
Upcoming events
No upcoming trial completions or earnings dates on record for this company's assets.
Regulatory and conference events
(1)
Filings, regulator decisions, scientific presentations, topline results and licensing deals, each from a dated source. When a source gives only the month, the month is shown.
Recent
27 October 2026Topline resultODX (Osteodex)Myeloma study: clinical study report completed; preliminary results confirmed
DexTech Medical AB · Source ↗
Financial reports
Annual history (1 year)
| Period | Revenue | R&D | Cash & equiv. | Net loss / qtr | Filing |
|---|---|---|---|---|---|
| 2025-FY | $0 | — | $1.6M | $0.1M | report ↗ |